Tomas Hradec

21PUBLICATIONS
46CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 06, 2026
Impact of Chemotherapy on Sperm Functional Characteristics in Patients With Testicular Germ Cell Tumours.

Ondrej Sanovec, Ondrej Simonik, Zuzana Kratka

|Jan 07, 2026
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study.

Thomas Büttner, Mimma Rizzo, Laura Bernal Vaca

|Dec 01, 2025
Second Primary Cancer After Bladder Cancer: A Comprehensive Analysis of a National Cancer Registry.

Tomas Buchler, Lucie Pehalova Kusova, Alina Pirshtuk

|May 16, 2025
Relugolix in Combination with Androgen Receptor Pathway Inhibitors in the Treatment of Metastatic Prostate Cancer: A Clinical Perspective.

Tomas Buchler

|Jun 06, 2024
Fecal miRNA profiles in colorectal cancers with mucinous morphology.

Alessio Naccarati, Mihnea P Dragomir, Sonia Tarallo

|Feb 03, 2024
Planned Discontinuation of Tyrosine Kinase Inhibitor Therapy in Metastatic Renal Cell Carcinoma: Lessons for the Era of Immunotherapy.

Tomas Buchler, Alexandr Poprach

Pageof 4

Frequent Collaborators

2 joint publications

Veronika Vymetalkova

2 joint publications

Pavel Vodicka

2 joint publications

Ondřej Fiala

2 joint publications

Francesco Massari